Log In
Print
BCIQ
Print
Print this Print this
 

Recentin, cediranib (AZD2171)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionTyrosine kinase inhibitor (TKI) of VEGFR-1, VEGFR-2 and VEGFR-3
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today